Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_assertion type Assertion NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_head.
- NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_assertion description "[Three months after initiation of TCZ therapy, changes in swollen joint count (SJC) and, subordinately, tender joint count (TJC), serum-CRP, DAS28-CRP, and EULAR-response were tested for association with the IL6R-haplotype or genotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_provenance.
- NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_assertion evidence source_evidence_literature NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_provenance.
- NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_assertion SIO_000772 24978393 NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_provenance.
- NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_assertion wasDerivedFrom befree-20150227 NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_provenance.
- NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_assertion wasGeneratedBy ECO_0000203 NP327597.RAdBJTllalYYeTUq9PEd-Mk7ReXigvtD_74GnLg6YDNxE130_provenance.